Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients

被引：10
作者：
Shah, Rajiv [1 ]
Baqai-Stern, Aisha [2 ]
Gulati, Amitabh [2 ]
机构：
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, Board Certified Anesthesiol & Pain Management, M308, New York, NY 10065 USA
来源：
CURRENT PAIN AND HEADACHE REPORTS | 2015年 / 19卷 / 06期
关键词：
Intrathecal drug delivery; Intrathecal medications; Cancer pain; Neuraxial trial; CHRONIC PAIN; MANAGEMENT; RECOMMENDATIONS; SELECTION; THERAPY; SYSTEM; IMPACT;
D O I：
10.1007/s11916-015-0488-x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient's disease course, and the management of complications related to the ITDD system and intrathecal medications.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Systemic Opioid Elimination After Implantation of an Intrathecal Drug Delivery System Significantly Reduced Health-Care Expenditures
    Hatheway, John A.
    Caraway, David
    David, Guy
    Gunnarsson, Candace
    Hinnenthal, Jennifer
    Ernst, Amanda R.
    Saulino, Michael
    NEUROMODULATION, 2015, 18 (03): : 207 - 213
  • [22] Intrathecal Pumps for Managing Cancer Pain
    Textor, Laura Hanssen
    AMERICAN JOURNAL OF NURSING, 2016, 116 (05) : 36 - 44
  • [23] Refill Port Identification of Intrathecal Drug Delivery System Devices With a Raised Fill Port
    Maino, Paolo
    van Kuijk, Sander M. J.
    Koetsier, Eva
    PAIN PRACTICE, 2019, 19 (04) : 418 - 425
  • [24] Intrathecal drug delivery systems for cancer pain: A retrospective analysis at a single tertiary medical center in China
    Wang, Wen
    Shi, Qing
    Cao, Yanting
    Fan, Bifa
    Yang, Yang
    HELIYON, 2024, 10 (14)
  • [25] Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management: A Review and Updates
    Upadhyay, Surjya Prasad
    Mallick, Piyush N.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2012, 29 (05) : 388 - 398
  • [26] Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations
    Duarte, Rui V.
    Lambe, Tosin
    Raphael, Jon H.
    Eldabe, Sam
    Andronis, Lazaros
    PAIN PRACTICE, 2018, 18 (05) : 666 - 686
  • [27] Initial Intrathecal Dose Titration and Predictors of Early Dose Escalation in Patients With Cancer Using a 100:1 Oral to Intrathecal Morphine Conversion Ratio
    Sindt, Jill E.
    Odell, Daniel W.
    Tariq, Rayhan
    Presson, Angela P.
    Zhang, Chong
    Brogan, Shane E.
    NEUROMODULATION, 2021, 24 (07): : 1157 - 1166
  • [28] Complications associated with intrathecal drug delivery systems
    Delhaas, E. M.
    Huygen, F. J. P. M.
    BJA EDUCATION, 2020, 20 (02) : 51 - 57
  • [29] Intrathecal Drug Delivery Systems Survey: Trends in Utilization in Pain Practice
    Abd-Sayed, Alaa
    Fiala, Kenneth
    Weibstein, Jacqueline
    Chopra, Pooja
    Lam, Christopher
    Kalia, Hemant
    Jassal, Navdeep
    Gulati, Amitabh
    Sayed, Dawood
    Deer, Timothy
    Abd-Sayed, Alaa
    JOURNAL OF PAIN RESEARCH, 2022, 15 : 1305 - 1314
  • [30] Plain radiography in patients treated with intrathecal drug delivery using an implantable pump device
    Delhaas, Elmar M.
    Harhangi, Biswadjiet S.
    Frankema, Sander P. G.
    Huygen, Frank J. P. M.
    van der Lugt, Aad
    INSIGHTS INTO IMAGING, 2017, 8 (05): : 499 - 511
12345